Stephen Brady
Chief Executive Officer bei TEMPEST THERAPEUTICS, INC.
Vermögen: 11 730 $ am 31.03.2024
Profil
Stephen R.
Brady is currently the President, Chief Executive Officer & Director at Tempest Therapeutics, Inc. He is also a Director at Biotechnology Innovation Organization and an Independent Director at Atreca, Inc. Previously, he held positions as the Director-Corporate Development at Proteolix, Inc., Vice President at Lazard Frères & Co. LLC, Senior Corporate Counsel at Lexicon Pharmaceuticals, Inc., President & Chief Operating Officer at TempestTx, Inc., Associate at Morrison & Foerster LLP, and Executive Vice President-Strategy & Finance at Immune Design Corp.
He also served as the VP-Corporate Development, Strategy & Operations at Sagimet Biosciences, Inc. Mr. Brady obtained his undergraduate degree from the University of Oregon and his graduate degrees from the University of the Pacific and New York University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.01.2024 | 3 000 ( 0,01% ) | 11 730 $ | 31.03.2024 | |
ATRECA, INC. CLASS A
-.--% | 13.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Stephen Brady
| Unternehmen | Position | Beginn |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Chief Executive Officer | 01.06.2021 |
| ATRECA, INC. | Director/Board Member | 14.07.2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01.01.2022 |
Ehemalige bekannte Positionen von Stephen Brady
| Unternehmen | Position | Ende |
|---|---|---|
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | President | 01.06.2021 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 02.04.2019 |
| SAGIMET BIOSCIENCES INC. | Chief Operating Officer | 11.02.2011 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | General Counsel | 25.03.2009 |
| LEXICON PHARMACEUTICALS, INC. | General Counsel | 01.01.2007 |
Ausbildung von Stephen Brady
| University of Oregon | Undergraduate Degree |
| University of the Pacific | Graduate Degree |
| New York University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Lazard Frères & Co. LLC
 Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Commercial Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
